BACKGROUND AND OBJECTIVES: The profound organ shortage has resulted in longer waiting times and increased mortality for those awaiting kidney transplantation. Consequently, patients are turning to older living donors. It is unclear if an upper age limit for donation should exist, both in terms of recipient and donor outcomes. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In the United States, 219 healthy adults aged ≥70 have donated kidneys at 80 of 279 transplant centers. Competing risks models with matched controls were used to study the independent association between older donor age and allograft survival, accounting for the competing risk of recipient mortality as well as other transplant factors. RESULTS: Among recipients of older live donor allografts, graft loss was significantly higher than matched 50-to 59-year-old live donor allografts (subhazard ratio [SHR] 1.62, 95% confidence interval [CI] 1.16 to 2.28, P = 0.005) but similar to matched nonextended criteria 50-to 59-year-old deceased donor allografts (SHR 1.19, 95% CI 0.87 to 1.63, P = 0.3). Mortality among living kidney donors aged ≥70 was no higher than healthy matched controls drawn from the NHANES-III cohort; in fact, mortality was lower, probably reflecting higher selectivity among older live donors than could be captured in National Health and Nutrition Examination Survey III (NHANES-III; HR 0.37, 95% CI 0.21 to 0.65, P < 0.001). CONCLUSIONS: These findings support living donation among older adults but highlight the advantages of finding a younger donor, particularly for younger recipients.
BACKGROUND AND OBJECTIVES: The profound organ shortage has resulted in longer waiting times and increased mortality for those awaiting kidney transplantation. Consequently, patients are turning to older living donors. It is unclear if an upper age limit for donation should exist, both in terms of recipient and donor outcomes. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In the United States, 219 healthy adults aged ≥70 have donated kidneys at 80 of 279 transplant centers. Competing risks models with matched controls were used to study the independent association between older donor age and allograft survival, accounting for the competing risk of recipient mortality as well as other transplant factors. RESULTS: Among recipients of older live donor allografts, graft loss was significantly higher than matched 50-to 59-year-old live donor allografts (subhazard ratio [SHR] 1.62, 95% confidence interval [CI] 1.16 to 2.28, P = 0.005) but similar to matched nonextended criteria 50-to 59-year-old deceased donor allografts (SHR 1.19, 95% CI 0.87 to 1.63, P = 0.3). Mortality among living kidney donors aged ≥70 was no higher than healthy matched controls drawn from the NHANES-III cohort; in fact, mortality was lower, probably reflecting higher selectivity among older live donors than could be captured in National Health and Nutrition Examination Survey III (NHANES-III; HR 0.37, 95% CI 0.21 to 0.65, P < 0.001). CONCLUSIONS: These findings support living donation among older adults but highlight the advantages of finding a younger donor, particularly for younger recipients.
Authors: Robert A Montgomery; Sommer E Gentry; William H Marks; Daniel S Warren; Janet Hiller; Julie Houp; Andrea A Zachary; J Keith Melancon; Warren R Maley; Hamid Rabb; Christopher Simpkins; Dorry L Segev Journal: Lancet Date: 2006-07-29 Impact factor: 79.321
Authors: Robert A Montgomery; Andrea A Zachary; Lloyd E Ratner; Dorry L Segev; Janet M Hiller; Julie Houp; Mathew Cooper; Louis Kavoussi; Thomas Jarrett; James Burdick; Warren R Maley; J Keith Melancon; Tomasz Kozlowski; Christopher E Simpkins; Melissa Phillips; Amol Desai; Vanessa Collins; Brigitte Reeb; Edward Kraus; Hamid Rabb; Mary S Leffell; Daniel S Warren Journal: JAMA Date: 2005-10-05 Impact factor: 56.272
Authors: Scott R Johnson; Khalid Khwaja; Martha Pavlakis; Anthony P Monaco; Douglas W Hanto Journal: Clin Transplant Date: 2005-10 Impact factor: 2.863
Authors: R A Wolfe; V B Ashby; E L Milford; A O Ojo; R E Ettenger; L Y Agodoa; P J Held; F K Port Journal: N Engl J Med Date: 1999-12-02 Impact factor: 91.245
Authors: A B Leichtman; D Cohen; D Keith; K O'Connor; M Goldstein; V McBride; C J Gould; L L Christensen; V B Ashby Journal: Am J Transplant Date: 2008-04 Impact factor: 8.086
Authors: Fawaz Al Ammary; Xun Luo; Abimereki D Muzaale; Allan B Massie; Deidra C Crews; Madeleine M Waldram; Mohamud A Qadi; Jacqueline Garonzik-Wang; Macey L Henderson; Daniel C Brennan; Alexander C Wiseman; Richard C Lindrooth; Jon J Snyder; Josef Coresh; Dorry L Segev Journal: Clin J Am Soc Nephrol Date: 2019-06-25 Impact factor: 8.237
Authors: Naim Issa; Lisa E Vaughan; Aleksandar Denic; Walter K Kremers; Harini A Chakkera; Walter D Park; Arthur J Matas; Sandra J Taler; Mark D Stegall; Joshua J Augustine; Andrew D Rule Journal: Am J Transplant Date: 2019-02-01 Impact factor: 8.086
Authors: Jane C Tan; Elisa J Gordon; Mary Amanda Dew; Dianne LaPointe Rudow; Robert W Steiner; E Steve Woodle; Rebecca Hays; James R Rodrigue; Dorry L Segev Journal: Clin J Am Soc Nephrol Date: 2015-04-23 Impact factor: 8.237
Authors: A B Massie; J Leanza; L M Fahmy; E K H Chow; N M Desai; X Luo; E A King; M G Bowring; D L Segev Journal: Am J Transplant Date: 2016-02-26 Impact factor: 8.086
Authors: P P Reese; R D Bloom; H I Feldman; P Rosenbaum; W Wang; P Saynisch; N M Tarsi; N Mukherjee; A X Garg; A Mussell; J Shults; O Even-Shoshan; R R Townsend; J H Silber Journal: Am J Transplant Date: 2014-07-09 Impact factor: 8.086
Authors: Kyle J Van Arendonk; Nathan T James; Babak J Orandi; Jacqueline M Garonzik-Wang; Jodi M Smith; Paul M Colombani; Dorry L Segev Journal: Transplantation Date: 2013-09-15 Impact factor: 4.939
Authors: Bertram L Kasiske; Teresa Anderson-Haag; Hassan N Ibrahim; Todd E Pesavento; Matthew R Weir; Joseph M Nogueira; Fernando G Cosio; Edward S Kraus; Hamid H Rabb; Roberto S Kalil; Andrew A Posselt; Paul L Kimmel; Michael W Steffes Journal: Am J Kidney Dis Date: 2013-03-22 Impact factor: 8.860